2-(4-氧代-1H-喹唑啉-2-基)苯甲酸 | 35729-61-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 2-(4-氧代-1H-喹唑啉-2-基)苯甲酸
• 英文名称: 2-(4-oxo-1,4-dihydroquinazolin-2-yl)benzoic acid
• 英文别名: 2-(4-oxo-3,4-dihydroquinazolin-2-yl)benzoic acid；2-(4-oxo-3,4-dihydro-quinazolin-2-yl)-benzoic acid；2-(2'-Carboxyphenyl)-4-chinazolon；2-(o-Carboxyphenyl)-chinazolon-4；2-(4-oxo-1H-quinazolin-2-yl)benzoic acid
• CAS: 35729-61-4
• 化学式: C₁₅H₁₀N₂O₃
• 分子量: 266.256
• InChiKey: BXIXPQPMKDQMCW-UHFFFAOYSA-N

物化性质

• 熔点：
  >290 °C(Solv: 1,4-dioxane (123-91-1))
• 沸点：
  508.7±52.0 °C(Predicted)
• 密度：
  1.40±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  78.8
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  2-(4-氧代-1H-喹唑啉-2-基)苯甲酸 在 sodium acetate 作用下， 以 乙酸酐 为溶剂， 生成 isoindolo[1,2-b]quinazoline-10,12-dione
  参考文献：
  名称：

  Reaction of anthranilic acid amides with cyclic anhydrides

  摘要：

  Anthranilic acid amide reacts with cyclic anhydrides to give the corresponding N-acyl derivatives at the amino group, while analogous reactions of o-aminobenzohydroxamic acid lead to fori-nation of 3-hydroxy-quinazolin-4-ones under mild conditions. N-Acyl derivatives of anthranilic acid amide undergo intramolecular cyclization to imides on microwave irradiation or on melting, and their treatment with acetic anhydride in the presence of sodium acetate on heating yields quinazolin-4-ones.

  DOI：

  10.1134/s1070428006030079
• 作为产物：
  描述：

  2-氨基-N-羟基苯甲酰胺 在 potassium carbonate 、 对甲苯磺酸 作用下， 以 水 、 二甲基亚砜 、 氯苯 为溶剂， 反应 7.0h， 生成 2-(4-氧代-1H-喹唑啉-2-基)苯甲酸
  参考文献：
  名称：

  合成新型含喹唑啉的异羟肟酸作为潜在的HDAC / VEGFR抑制剂。具有吡咯烷酮开环的异常重排和含有四环的3-N-羟基喹唑啉片段的脱水

  摘要：

  开发了合成途径并获得了新的异羟肟酸作为HDAC / VEGFR2的潜在抑制剂，包括以喹唑啉酮片段为“帽”的四环。对获得的化合物进行进一步的生物学测试将为评估所选研究方向的实际前景提供机会。

  DOI：

  10.1016/j.tetlet.2019.151315

文献信息

• Chibani, A.; Hazard, R.; Tallec, A., Bulletin de la Societe Chimique de France, 1991, # 6, p. 814 - 822
  作者：Chibani, A.、Hazard, R.、Tallec, A.

  DOI：——

  日期：——
• HEYMAN D. A., J. HETEROCYCL. CHEM., 1978, 15, NO 4, 573-576
  作者：HEYMAN D. A.

  DOI：——

  日期：——
• NOVEL QUINAZOLINONES AS BROMODOMAIN INHIBITORS
  申请人：Zenith Epigenetics Ltd.

  公开号：EP3027604B1

  公开（公告）日：2019-02-20
• HEME OXYGENASE INHIBITORS, SCREENING METHODS FOR HEME OXYGENASE INHIBITORS AND METHODS OF USE OF HEME OXYGENASE INHIBITORS FOR ANTIMICROBIAL THERAPY
  申请人：Wilks Angela

  公开号：US20100081661A1

  公开（公告）日：2010-04-01

  Inhibitors of microbial heme oxygenase and their use for treatment of microbial infections and bioremediation. The inhibitors of microbial heme oxygenase are useful against a new class of antimicrobial agents to target infections that are persistently difficult to combat with the current spectrum of antimicrobial agents. Screening methods for selecting inhibitors of microbial heme oxygenase.
• INHIBITOR OF HEME DEGRADATION FOR USE TO IMPROVE ANTIBIOTIC TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTION
  申请人：The United States of America, as represented by the Secretary, Department of Health and Human Serv

  公开号：US20190201414A1

  公开（公告）日：2019-07-04

  The present invention provides a method of preventing or treating a Mycobacterium tuberculosis (Mtb) infection in a mammal the method comprising administering to the mammal a first inhibitor, wherein the first inhibitor is an inhibitor of heme degradation and wherein the first inhibitor is a metal protoporphyrin, and administering to the mammal a second inhibitor, wherein the second inhibitor is an inhibitor of Mtb, wherein administration of the first and second inhibitors to the mammal prevents or treats Mtb infection in the mammal.